# Efficacy and Performance Evaluation of mGlobal L+AS 20 mg/ml Hyaluronic Acid, for the Correction of Light to Moderate Wrinkles and Folds

> **NCT06482723** · NA · COMPLETED · sponsor: **Mesoestetic Pharma Group S.L.** · enrollment: 42 (actual)

## Conditions studied

- Skin Aging
- Skin Wrinkling

## Interventions

- **DEVICE:** mGlobal L+AS

## Key facts

- **NCT ID:** NCT06482723
- **Lead sponsor:** Mesoestetic Pharma Group S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-03
- **Primary completion:** 2023-08-03
- **Final completion:** 2023-08-03
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06482723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06482723, "Efficacy and Performance Evaluation of mGlobal L+AS 20 mg/ml Hyaluronic Acid, for the Correction of Light to Moderate Wrinkles and Folds". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06482723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*